Patents by Inventor Yury A. Bochkov

Yury A. Bochkov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10280405
    Abstract: The present invention provides methods of propagating rhinovirus C (RV-C) in a host cell; a host cell comprising an effective amount of a heterologous CDHR3 receptor such that the host cell can support propagation of rhinovirus C; and kits comprising at least one host cell previously unable to support rhinovirus C growth, wherein the host cell comprises a heterologous CDHR3 receptor and a sample of rhinovirus C. Methods of use are also provided.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: May 7, 2019
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: James E. Gern, Yury A. Bochkov, Ann C. Palmenberg
  • Patent number: 10253300
    Abstract: A mutated rhinovirus C, methods of creating and methods of propagating thereof, wherein the mutated rhinovirus shows enhanced virus yields after infection and induced visible cytopathic effect.
    Type: Grant
    Filed: August 10, 2016
    Date of Patent: April 9, 2019
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Yury A. Bochkov, James E. Gern, Ann C. Palmenberg, Kelly E. Watters
  • Publication number: 20190055521
    Abstract: The present invention provides methods of propagating rhinovirus C (RV-C) in a host cell; a host cell comprising an effective amount of a heterologous CDHR3 receptor such that the host cell can support propagation of rhinovirus C; and kits comprising at least one host cell previously unable to support rhinovirus C growth, wherein the host cell comprises a heterologous CDHR3 receptor and a sample of rhinovirus C. Methods of use are also provided.
    Type: Application
    Filed: March 6, 2018
    Publication date: February 21, 2019
    Inventors: James E. Gern, Yury A. Bochkov, Ann C. Palmenberg
  • Patent number: 9938507
    Abstract: The present invention provides methods of propagating rhinovirus C (RV-C) in a host cell; a host cell comprising an effective amount of a heterologous CDHR3 receptor such that the host cell can support propagation of rhinovirus C; and kits comprising at least one host cell previously unable to support rhinovirus C growth, wherein the host cell comprises a heterologous CDHR3 receptor and a sample of rhinovirus C. Methods of use are also provided.
    Type: Grant
    Filed: August 26, 2015
    Date of Patent: April 10, 2018
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: James E. Gern, Yury A. Bochkov, Ann C. Palmenberg
  • Publication number: 20170082609
    Abstract: The present invention provides methods of propagating rhinovirus C (RV-C) in a host cell; a host cell comprising an effective amount of a heterologous CDHR3 receptor such that the host cell can support propagation of rhinovirus C; and kits comprising at least one host cell previously unable to support rhinovirus C growth, wherein the host cell comprises a heterologous CDHR3 receptor and a sample of rhinovirus C. Methods of use are also provided.
    Type: Application
    Filed: August 26, 2015
    Publication date: March 23, 2017
    Inventors: James E. Gern, Yury A. Bochkov, Ann C. Palmenberg
  • Publication number: 20170044503
    Abstract: A mutated rhinovirus C, methods of creating and methods of propagating thereof, wherein the mutated rhinovirus shows enhanced virus yields after infection and induced visible cytopathic effect.
    Type: Application
    Filed: August 10, 2016
    Publication date: February 16, 2017
    Inventors: Yury A. Bochkov, James E. Gern, Ann C. Palmenberg, Kelly E. Watters
  • Publication number: 20070243169
    Abstract: The invention provides a method of inhibiting Ran protein activity in at least one eukaryotic cell or cell-free extract, the method comprising exposing an amino acid sequence comprising at least a portion of EMCV or TMEV leader protein, wherein the amino acid sequence comprises SEQ. ID NO: 14 or SEQ. ID NO: 15, to at least one cell in an amount effective to inhibit Ran activity in the targeted cell and evaluating Ran protein activity in the cell.
    Type: Application
    Filed: January 18, 2007
    Publication date: October 18, 2007
    Inventors: Frederick Porter, Ann Palmenberg, Christiane Wiese, Yury Bochkov